CCL19 and inflammatory bowel disease: Results from the IVW analysis demonstrated that genetically predicted levels of the inflammatory factors C-C motif chemokine 19 (CCL19) (OR = 1.11, 95% CI = 1.04–1.19, P = .003) was significantly positively associated with an elevated risk of IBD.